Bidirectional Mendelian randomization analysis of the causal association between obesity and hepatocellular carcinoma in a European population. [PDF]
Ding X +12 more
europepmc +1 more source
N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen +6 more
wiley +1 more source
<i>DNASE1L3</i> Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/<b>β</b>-Catenin Signaling Pathway. [PDF]
Zhang S +7 more
europepmc +1 more source
Gut microbiome‐derived metabolites show promise in cancer research and therapy
The metabolites produced by the gut microbiome, which are subject to regulation by multiple factors, play a pivotal role in the progression of various types of cancer. These metabolites not only function as potential biomarkers for the early detection and monitoring of tumor development, but also actively participate in cancer therapeutic processes ...
Kangjie Yang +4 more
wiley +1 more source
Regulation of Autophagy and Metabolism in Hepatocellular Carcinoma: Involvement of Wnt-β-Catenin Pathway. [PDF]
Roy SK +5 more
europepmc +1 more source
Reframing Post‐Hepatectomy Liver Failure as a Determinant of Post‐Recurrence Survival in HCC
ABSTRACT Background Post‐hepatectomy liver failure (PHLF) is traditionally considered a transient perioperative complication with limited long‐term consequences, yet its long‐term oncologic implications in hepatocellular carcinoma (HCC) remain unclear. Methods Patients undergoing primary hepatectomy for HCC between 2007 and 2018 were analyzed.
Hiroshi Horie +7 more
wiley +1 more source
CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness. [PDF]
Wang J +12 more
europepmc +1 more source
Relative telomer length as a potential biomarker in hepatocellular carcinoma: a comparative study of HCV patients treated with direct antiviral agent. [PDF]
Helal M +4 more
europepmc +1 more source
CXCL1-overexpressing cancer-associated fibroblasts stimulate hepatocellular carcinoma progression via neutrophil recruitment, NET formation, and immune suppression. [PDF]
Bi B +5 more
europepmc +1 more source

